+关注
Whateverrr
暂无个人介绍
IP属地:未知
13
关注
6
粉丝
0
主题
0
勋章
主贴
热门
Whateverrr
2021-04-13
起飞吧
SoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger
Whateverrr
2021-04-28
Keep innovating, Albert [开心]
Pfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes
Whateverrr
2021-04-22
回复
@LHZheng
:Comment//
@LHZheng
:Comment and like
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3575089959457206,"uuid":"3575089959457206","gmtCreate":1613376830034,"gmtModify":1617431298839,"name":"Whateverrr","pinyin":"whateverrr","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":13,"tweetSize":49,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":6,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.25","exceedPercentage":"60.11%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":377782830,"gmtCreate":1619565835920,"gmtModify":1634211814215,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep innovating, Albert [开心] ","listText":"Keep innovating, Albert [开心] ","text":"Keep innovating, Albert [开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/377782830","repostId":"1114427491","repostType":4,"repost":{"id":"1114427491","pubTimestamp":1619536730,"share":"https://www.laohu8.com/m/news/1114427491?lang=&edition=full","pubTime":"2021-04-27 23:18","market":"us","language":"en","title":"Pfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=1114427491","media":"CNBC","summary":"Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by","content":"<div>\n<p>Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 23:18 GMT+8 <a href=https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1114427491","content_text":"Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first authorized Covid-19 vaccine in the U.S. with German drugmakerBioNTech,began in Marchan early-stage clinical trial testing a new antiviral therapy for Covid. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.\nProtease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.\nIf clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed across the U.S. by the end of the year, Bourla told CNBC’s “Squawk Box.”\nHealth experts say the drug, taken by mouth, could be a gamechanger because people newly infected with the virus could use it outside of hospitals. Researchers hope the medication will keep the disease from progressing and prevent hospital trips.\nIn addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children. Vaccinating children is crucial to ending the pandemic, public health officials and infectious disease experts say.\nEarlier this month, the company asked the FDA to expand its vaccine authorization to adolescents ages 12 to 15 afterthe shot was found to be 100% effective in a study.\nBourla told CNBC on Tuesday he is “very optimistic” that the FDA will approve the use of the shot in adolescents.","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":376352015,"gmtCreate":1619092973937,"gmtModify":1634288637956,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"回复 <a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment//<a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment and like","listText":"回复 <a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment//<a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment and like","text":"回复 @LHZheng:Comment//@LHZheng:Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/376352015","repostId":"1143508710","repostType":4,"isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":345688842,"gmtCreate":1618309377986,"gmtModify":1634293816378,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"起飞吧","listText":"起飞吧","text":"起飞吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345688842","repostId":"1101547328","repostType":4,"repost":{"id":"1101547328","pubTimestamp":1618308239,"share":"https://www.laohu8.com/m/news/1101547328?lang=&edition=full","pubTime":"2021-04-13 18:03","market":"us","language":"en","title":"SoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1101547328","media":"cnbc","summary":"KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger ","content":"<div>\n<p>KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 18:03 GMT+8 <a href=https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1101547328","content_text":"KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in cash, which includes $4 billion in a private investment in public equity (PIPE).Upon completion of its merger, the SoftBank-backed company will trade on the Nasdaq under ticker symbol \"GRAB.\"Southeast Asia's ride-hailing giant Grab announced Tuesday that it's set to go public through a SPAC merger with Altimeter Growth Corp., in a deal that values the company at $39.6 billion — the largest blank-check merger to date.Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion.SPACs, or special purpose acquisition companies, are shell companies or blank-check companies set up for the purpose of raising capital to acquire private companies. A SPAC listing bypasses Wall Street's traditional IPO process.As part of the mega-deal, SoftBank-backed Grab will receive about $4.5 billion in cash, which includes $4 billion in a private investment in public equity (PIPE), managed byBlackRock, Fidelity,T. Rowe Price, Morgan Stanley’s Counterpoint Global fund and Singapore’s sovereign wealth fund Temasek. PIPEs are mechanisms for companies to raise capital from a select group of investors that make the final market debut possible through their financing.Grab — most recentlyranked No. 16on last year’sCNBC Disruptor 50list — delivers an array of digital services such as transportation, food delivery, hotel bookings, online banking, mobile payments and insurance services from its app. The Singapore-based company has operations throughout most of Southeast Asia, and serves more than 187 million users in over 350 cities across eight countries.While SPACs have become a hot investment vehicle on Wall Street, they’re alsogaining traction in Asiawith six regional-focused SPAC companies that have collectively raised $2.7 billion thus far in 2021.But in the first quarter this year, capital raised by blank-check firms like Altimeter has already outpaced 2020′s total issuance.It’s not onlydrawn the attentionof the U.S. Securities and Exchange Commission, but also investors who are fearful of a market bubble.Still, new deals continue to flood the market — more than 100 in March alone, according to SPAC Research.While Grab’s merger remains record-setting, Boston-based biotech company Ginkgo Bioworks,ranked No. 44on last year’sCNBC Disruptor 50list, is said to be considering an equally-massive $20 billion blank-check merger of its own,according to Bloomberg.Throughout the pandemic, Southeast Asiasaw a surgein the use of digital services like e-commerce, food delivery and online payment. As many as 40 million people in six countries across the region — Singapore, Malaysia, Indonesia, the Philippines, Vietnam and Thailand — came online for the first time in 2020, according to a report from Google, Temasek Holdings and Bain & Company.Still, Covid-19 has forced regional private market decacorns (start-ups valued at more than $10 billion)to cut staff and rethinkwhat will define a dominant “super app” suite of on-demand services. It’s also intensified the competitive landscape in an already saturated market that’s proven difficult to turn a profit.After a period of intense and expensive competition byUberto dominate rideshare in many markets, Indonesian rival Gojek sold its Southeast Asia business to Grab three years ago in return for Uber receiving a stake in the company.In January, Reutersreportedthat Grab’s net revenue had grown 70% year over year, recovering to pre-pandemic levels with its ride-hailing business breaking even in all operating markets, including its largest, Indonesia.Grab and Gojek were reportedly close to finalizing a merger of their own late last year.Reuters reportedthat Gojek — which isranked No. 10on last year’sCNBC Disruptor 50list — is now in advanced talks with Indonesian e-commerce leader Tokopedia for an $18 billion merger, ahead of a potential dual listing in Jakarta and the U.S.Grab Investor Presentation:","news_type":1},"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":345688842,"gmtCreate":1618309377986,"gmtModify":1634293816378,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"起飞吧","listText":"起飞吧","text":"起飞吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345688842","repostId":"1101547328","repostType":4,"repost":{"id":"1101547328","pubTimestamp":1618308239,"share":"https://www.laohu8.com/m/news/1101547328?lang=&edition=full","pubTime":"2021-04-13 18:03","market":"us","language":"en","title":"SoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1101547328","media":"cnbc","summary":"KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger ","content":"<div>\n<p>KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftBank-backed Grab agrees to deal to go public in world's largest SPAC merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 18:03 GMT+8 <a href=https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/04/13/softbank-backed-grab-agrees-to-deal-to-go-public-in-worlds-largest-spac-merger.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1101547328","content_text":"KEY POINTSSoutheast Asia's ride-hailing giant Grab is going public via a record-setting SPAC merger with Altimeter Growth Corp, valued at nearly $40 billion.Grab will receive about $4.5 billion in cash, which includes $4 billion in a private investment in public equity (PIPE).Upon completion of its merger, the SoftBank-backed company will trade on the Nasdaq under ticker symbol \"GRAB.\"Southeast Asia's ride-hailing giant Grab announced Tuesday that it's set to go public through a SPAC merger with Altimeter Growth Corp., in a deal that values the company at $39.6 billion — the largest blank-check merger to date.Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion.SPACs, or special purpose acquisition companies, are shell companies or blank-check companies set up for the purpose of raising capital to acquire private companies. A SPAC listing bypasses Wall Street's traditional IPO process.As part of the mega-deal, SoftBank-backed Grab will receive about $4.5 billion in cash, which includes $4 billion in a private investment in public equity (PIPE), managed byBlackRock, Fidelity,T. Rowe Price, Morgan Stanley’s Counterpoint Global fund and Singapore’s sovereign wealth fund Temasek. PIPEs are mechanisms for companies to raise capital from a select group of investors that make the final market debut possible through their financing.Grab — most recentlyranked No. 16on last year’sCNBC Disruptor 50list — delivers an array of digital services such as transportation, food delivery, hotel bookings, online banking, mobile payments and insurance services from its app. The Singapore-based company has operations throughout most of Southeast Asia, and serves more than 187 million users in over 350 cities across eight countries.While SPACs have become a hot investment vehicle on Wall Street, they’re alsogaining traction in Asiawith six regional-focused SPAC companies that have collectively raised $2.7 billion thus far in 2021.But in the first quarter this year, capital raised by blank-check firms like Altimeter has already outpaced 2020′s total issuance.It’s not onlydrawn the attentionof the U.S. Securities and Exchange Commission, but also investors who are fearful of a market bubble.Still, new deals continue to flood the market — more than 100 in March alone, according to SPAC Research.While Grab’s merger remains record-setting, Boston-based biotech company Ginkgo Bioworks,ranked No. 44on last year’sCNBC Disruptor 50list, is said to be considering an equally-massive $20 billion blank-check merger of its own,according to Bloomberg.Throughout the pandemic, Southeast Asiasaw a surgein the use of digital services like e-commerce, food delivery and online payment. As many as 40 million people in six countries across the region — Singapore, Malaysia, Indonesia, the Philippines, Vietnam and Thailand — came online for the first time in 2020, according to a report from Google, Temasek Holdings and Bain & Company.Still, Covid-19 has forced regional private market decacorns (start-ups valued at more than $10 billion)to cut staff and rethinkwhat will define a dominant “super app” suite of on-demand services. It’s also intensified the competitive landscape in an already saturated market that’s proven difficult to turn a profit.After a period of intense and expensive competition byUberto dominate rideshare in many markets, Indonesian rival Gojek sold its Southeast Asia business to Grab three years ago in return for Uber receiving a stake in the company.In January, Reutersreportedthat Grab’s net revenue had grown 70% year over year, recovering to pre-pandemic levels with its ride-hailing business breaking even in all operating markets, including its largest, Indonesia.Grab and Gojek were reportedly close to finalizing a merger of their own late last year.Reuters reportedthat Gojek — which isranked No. 10on last year’sCNBC Disruptor 50list — is now in advanced talks with Indonesian e-commerce leader Tokopedia for an $18 billion merger, ahead of a potential dual listing in Jakarta and the U.S.Grab Investor Presentation:","news_type":1},"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":377782830,"gmtCreate":1619565835920,"gmtModify":1634211814215,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep innovating, Albert [开心] ","listText":"Keep innovating, Albert [开心] ","text":"Keep innovating, Albert [开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/377782830","repostId":"1114427491","repostType":4,"repost":{"id":"1114427491","pubTimestamp":1619536730,"share":"https://www.laohu8.com/m/news/1114427491?lang=&edition=full","pubTime":"2021-04-27 23:18","market":"us","language":"en","title":"Pfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=1114427491","media":"CNBC","summary":"Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by","content":"<div>\n<p>Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s new at-home pill to treat Covid could be available by end of the year, CEO hopes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 23:18 GMT+8 <a href=https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1114427491","content_text":"Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.\nThe company, which developed the first authorized Covid-19 vaccine in the U.S. with German drugmakerBioNTech,began in Marchan early-stage clinical trial testing a new antiviral therapy for Covid. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.\nProtease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.\nIf clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed across the U.S. by the end of the year, Bourla told CNBC’s “Squawk Box.”\nHealth experts say the drug, taken by mouth, could be a gamechanger because people newly infected with the virus could use it outside of hospitals. Researchers hope the medication will keep the disease from progressing and prevent hospital trips.\nIn addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children. Vaccinating children is crucial to ending the pandemic, public health officials and infectious disease experts say.\nEarlier this month, the company asked the FDA to expand its vaccine authorization to adolescents ages 12 to 15 afterthe shot was found to be 100% effective in a study.\nBourla told CNBC on Tuesday he is “very optimistic” that the FDA will approve the use of the shot in adolescents.","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":376352015,"gmtCreate":1619092973937,"gmtModify":1634288637956,"author":{"id":"3575089959457206","authorId":"3575089959457206","name":"Whateverrr","avatar":"https://static.tigerbbs.com/4ae8e0be52e3982e271587ff7f4f9c54","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"回复 <a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment//<a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment and like","listText":"回复 <a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment//<a href=\"https://laohu8.com/U/3579931805911871\">@LHZheng</a>:Comment and like","text":"回复 @LHZheng:Comment//@LHZheng:Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/376352015","repostId":"1143508710","repostType":4,"isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}